Like EGFR mutations, KRAS mutations are frequently appearing genetic changes in NSCLC, found in 15% to 30% of NSCLC among Western patients, although the frequency is lower in Asian patients [6]–[11]. Here, KRAS is linked to non-small cell lung carcinoma.